
### [MONDO:0018646](http://purl.obolibrary.org/obo/MONDO_0018646)
**Label:** sclerosing cholangitis (disease)

**Subclasses:** [MONDO:0013433](http://purl.obolibrary.org/obo/MONDO_0013433) (primary sclerosing cholangitis), 

**Corr. equiv. classes:** [Orphanet:171](http://www.orpha.net/ORDO/Orphanet_171), [OMIM:602114](http://purl.obolibrary.org/obo/OMIM_602114), [OMIM:613806](http://purl.obolibrary.org/obo/OMIM_613806), 

**Class expressions from DL-Learner:**

- [HP:0100575](http://purl.obolibrary.org/obo/HP_0100575) (Neoplasm of the gallbladder) 66.67%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and [HP:0100871](http://purl.obolibrary.org/obo/HP_0100871) (Abnormality of the palm) 66.67%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and [HP:0100869](http://purl.obolibrary.org/obo/HP_0100869) (Palmar telangiectasia) 66.67%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and [HP:0100834](http://purl.obolibrary.org/obo/HP_0100834) (Neoplasm of the large intestine) 66.67%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and [HP:0100831](http://purl.obolibrary.org/obo/HP_0100831) (Abnormality of vitamin K metabolism) 66.67%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and [HP:0100763](http://purl.obolibrary.org/obo/HP_0100763) (Abnormality of the lymphatic system) 66.67%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and [HP:0100651](http://purl.obolibrary.org/obo/HP_0100651) (Type I diabetes mellitus) 66.67%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and [HP:0100646](http://purl.obolibrary.org/obo/HP_0100646) (Thyroiditis) 66.67%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and [HP:0100626](http://purl.obolibrary.org/obo/HP_0100626) (Chronic hepatic failure) 66.67%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and [HP:0100585](http://purl.obolibrary.org/obo/HP_0100585) (Telangiectasia of the skin) 66.67%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and [HP:0100575](http://purl.obolibrary.org/obo/HP_0100575) (Neoplasm of the gallbladder) 66.67%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and [HP:0100533](http://purl.obolibrary.org/obo/HP_0100533) (Inflammatory abnormality of the eye) 66.67%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and [HP:0100514](http://purl.obolibrary.org/obo/HP_0100514) (Abnormality of vitamin E metabolism) 66.67%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and [HP:0100513](http://purl.obolibrary.org/obo/HP_0100513) (Vitamin E deficiency) 66.67%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and [HP:0100512](http://purl.obolibrary.org/obo/HP_0100512) (Vitamin D deficiency) 66.67%


